Search Within

Gary Schwartz

  1. "Sarcoma Service"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (25)
Groups
  1. Department of Medicine (64)
  2. Sarcoma Service (64)
  3. Solid Tumor Oncology Division (64)
  4. GSK Faculty (29)
  5. Biostatistics Service (24)
  6. Epidemiology and Biostatistics (24)

More Groups

People
  1. Mark Dickson (40)
  2. Richard Carvajal (26)
  3. William Tap (26)
  4. Mary Keohan (21)
  5. Sandra D'Angelo (20)
  6. Cristina Antonescu (16)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2015 (2)
  4. 2014 (7)
  5. 2013 (20)
  6. 2012 (13)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Clinical Cancer Research (4)
  3. Cancer Research (3)
  4. British Journal of Cancer (2)
  5. Sarcoma (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (8)
  3. Wiley Blackwell (3)
  4. Hindawi Publishing Corporation (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors
    Journal Article

    Dickson, M. A.; Okuno, S. H.; Keohan, M. L.; Maki, R. G.; D'adamo, D. R.; Akhurst, T. J.; Antonescu, C. R.; Schwartz, G. K.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • A phase Ib/II study evaluating the efficacy of doxorubicin (D) with or without a human anti-PDGFR alpha monoclonal antibody olaratumab (IMC-3G3) in the treatment of advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Tap, W. D.; Van Tine, B. A.; Elias, A. D.; Livingston, M. B.; Agulnik, M.; Cooney, M. M.; Chmielowski, B.; Brenner, A. J.; Pennock, G. K.; Somaiah, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II multicenter study of the IGF-1 receptor antibody cixutumumab (A12) and the mTOR inhibitor temsirolimus (TEM) in patients (pts) with refractory IGF-1R positive (+) and negative (-) bone and soft tissue sarcomas (STS)
    Meeting Abstract

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S.; Reed, D. R.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma
    Meeting Abstract

    Gounder, M. M.; Dickson, M. A.; Wu, N.; Ivy, S. P.; Carvajal, R. D.; D'Angelo, S. P.; Keohan, M. L.; Qin, L. X.; Erinjeri, J. P.; Takebe, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save